Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer.
| Publicado en: | Breast Cancer Research Vol. 26; no. 1; pp. 1 - 16 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
7/25/2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178623514&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 178623514 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14655411 8UYJ jtl: Breast Cancer Research issn: 14655411 maglogo: N pubinfo: dt: 7/25/2024 vid: 26 iid: 1 pid: 24147 pub: BioMed Central artinfo: ui: 178623514 10.1186/s13058-024-01873-y 178623514 ppf: 1 ppct: 15 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer. aug: au: Hao, Jiaqing Jin, Rong Yi, Yanmei Jiang, Xingshan Yu, Jianyu Xu, Zhen Schnicker, Nicholas J. Chimenti, Michael S. Sugg, Sonia L. Li, Bing affil: https://ror.org/036jqmy94 Department of Pathology, University of Iowa, 431 Newton Road, 52242, Iowa City, IA, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|